简体中文

Popular search

Recently visited pages

    Back to News
    ARC Group Wins at Hong Kong Commercial Times Business Awards 2023
    News | 15 May, 2023

    ARC Group Wins at Hong Kong Commercial Times Business Awards 2023

    On April 20, ARC Group was awarded Outstanding Financial Advisory Services of the Year at the Hong Kong Commercial Times Business Awards 2023.

    Our Managing Partner, Crystal Zhang, and Managing Director at the Hong Kong office, Edward Sit, attended the ceremony to receive the award.

    We are very proud to have received this recognition and continue to strive to improve and offer the best services to our clients. Thank you Hong Kong Commercial Times for a great ceremony!

    Continue reading

    ARC Group Promotes Charlene Lui to Director
    News | 10 August, 2026

    ARC Group Promotes Charlene Lui to Director

    ARC Group is pleased to announce the promotion of Charlene Lui to Director. Based in Hong Kong, Charlene is a member of the firm’s M&A team, where she has built a track record of originating and overseeing new business opportunities and client engagements from initial pitch through transaction closing, helping drive ARC Group’s deal pipeline […]
    2026 Capital Markets and M&A Forum Returns to the Bund in Shanghai This Fall, Spotlighting Overseas Listings, Cross-Border M&A, and the Global Expansion of Chinese Enterprises
    News | 06 August, 2026

    2026 Capital Markets and M&A Forum Returns to the Bund in Shanghai This Fall, Spotlighting Overseas Listings, Cross-Border M&A, and the Global Expansion of Chinese Enterprises

    Shanghai, China, August 5, 2026 – ARC Group, a global investment bank and management consulting firm, today announced that the Capital Markets and M&A Forum 2026: China Edition will take place on September 3, 2026, at the Waldorf Astoria Shanghai on the Bund. This event brings together founders, executives, investors, and professional advisors to explore […]
    ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)
    News | 09 July, 2026

    ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

    HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
    Rising Together | ARC Dragon Boat Team Takes to the Water
    News | 18 June, 2026

    Rising Together | ARC Dragon Boat Team Takes to the Water

    As the Dragon Boat Festival comes around again, so do its oldest rhythms: the long hulls slicing through water, the steady beat of the drum, a crew pulling as one. It is a festival about resilience and forward drive and about finding a shared cadence with the people sitting beside you in the same boat. […]

    Please complete this form to download the case study

    This field is for validation purposes and should be left unchanged.
    (Required)
    *Required before submission